New York AG Interest In Off-Label Promotion Extends Beyond GSK, Forest

The New York Attorney General's interest in potential off-label promotion cases goes beyond pediatric use of antidepressants, New York State Assistant Attorney General Rose Firestein told a Food & Drug Law Institute advertising and promotion conference Sept. 13 in Washington, D.C